Siniti Herath, Bushra Haque, Kingston Yeung, Katelyn Jauregui, Brett Chambers, Linda Krogh, Manya Angley, Stephen Carter, Rohan Elliott, Fatemeh Emadi, Deborah Hawthorne, Faye McMillan, Rebekah Moles, Deborah Rigby, Frank Sanfilippo, Paul Yates, Jerry Yik, Jonathan Penm
{"title":"A formative evaluation of the implementation of a medication management transition of care stewardship service for patients discharged from rural and remote hospitals: A qualitative study of clinicians and patients.","authors":"Siniti Herath, Bushra Haque, Kingston Yeung, Katelyn Jauregui, Brett Chambers, Linda Krogh, Manya Angley, Stephen Carter, Rohan Elliott, Fatemeh Emadi, Deborah Hawthorne, Faye McMillan, Rebekah Moles, Deborah Rigby, Frank Sanfilippo, Paul Yates, Jerry Yik, Jonathan Penm","doi":"10.1016/j.sapharm.2026.08.007","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.08.007","url":null,"abstract":"<p><strong>Background: </strong>The transition of care from the hospital to the home is a period of high risk for medication-related errors. This risk is further increased in hospitals in rural and regional areas, which face unique challenges such as geographical isolation and limited access to healthcare and healthcare providers.</p><p><strong>Aim: </strong>To explore the formative perspectives of key stakeholders towards the implementation of a virtual Transitions of Care Stewardship (TOCS) service to improve medication management upon discharge from rural and regional hospitals, including facilitating a home medicines review (HMR).</p><p><strong>Method: </strong>An interview guide was developed using the updated Consolidated Framework for Implementation Research. Key stakeholders were identified through professional networks and local healthcare providers and approached to participate. Semi-structured interviews were conducted in person or virtually (videoconference or teleconference) with patients, pharmacists, medical practitioners, nurses and allied health professionals between August and September 2024. Interviews were audio-recorded, transcribed verbatim, and continued until data saturation was reached. Data analysis was conducted using the framework approach to identify themes.</p><p><strong>Results: </strong>In total, 37 interviews were conducted with healthcare professionals and patients in rural and regional New South Wales. Three main themes were identified: (1) factors affecting service acceptability (access to primary care, older patient demographic, health literacy, cultural acceptability of First Nations Peoples); (2) utilising existing components of healthcare (virtual pharmacists in rural areas, rural HMR-credentialed pharmacists, improving utilisation of allied health assistants, strategies to improve awareness); and (3) workflow of a TOCS pharmacist (coordination of HMR referral, importance of continuity).</p><p><strong>Conclusion: </strong>Overall, a medication-centred discharge service in the form of a virtual TOCS pharmacist and their facilitation of post-discharge HMRs were found to be an acceptable intervention to enhance continuity of medication management for patients discharged from hospital to home in rural and remote areas.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-08-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148892364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sumithra Devi Suppiah, Alison Beauchamp, Rahul Malhotra, Lita Sui Tjien Chew, Wern-Ee Tang, Natali Cvetanovska, Jason Talevski, Xilei Yang, Rebecca L Jessup
{"title":"Pharmacy-based interventions for patients with limited health literacy and chronic disease: A systematic review of intervention outcomes with a focus on co-design.","authors":"Sumithra Devi Suppiah, Alison Beauchamp, Rahul Malhotra, Lita Sui Tjien Chew, Wern-Ee Tang, Natali Cvetanovska, Jason Talevski, Xilei Yang, Rebecca L Jessup","doi":"10.1016/j.sapharm.2026.08.006","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.08.006","url":null,"abstract":"<p><strong>Background: </strong>Limited health literacy (LHL) is associated with poorer health outcomes and presents challenges for chronic disease management. Pharmacy-based interventions may support medication-related outcomes in this population; however, their effectiveness and the extent to which they incorporate co-design elements remain unclear.</p><p><strong>Objectives: </strong>To evaluate the effectiveness of pharmacy-based interventions for adults with chronic disease and LHL, and to examine the extent to which co-design elements are incorporated in intervention development.</p><p><strong>Methods: </strong>MEDLINE, CINAHL, Embase, PsycINFO, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched from inception to 30 June 2025. Randomised controlled trials evaluating pharmacy-based interventions among adults with chronic disease and LHL were included. Study selection, data extraction, and quality appraisal were conducted independently by two reviewers. Risk of bias was assessed using the Joanna Briggs Institute Critical Appraisal Tool. Findings were synthesised narratively due to substantial heterogeneity.</p><p><strong>Results: </strong>A total of 10,029 records were identified, with nine trials (13 publications) included. Intervention effects were heterogeneous across outcomes. Medication understanding improved most consistently, driven primarily by patient-centred medication labels, with more modest gains from universal medication schedules. Care-transition interventions showed reductions in adverse events in some trials, although findings were not consistent across trials. Medication adherence outcomes were inconsistent and not sustained across trials. Clinical outcomes were assessed less frequently and showed mixed effects. Evidence of differential effectiveness by health literacy was limited and inconsistently reported. Co-design elements were largely absent, with only one trial reporting patient and family involvement. All trials were rated as low or moderate risk of bias, with none at high risk.</p><p><strong>Conclusion: </strong>Pharmacy-based interventions demonstrate mixed effectiveness in individuals with LHL, with stronger evidence for improving medication understanding and potential benefits in care transitions, but inconsistent effects on adherence and clinical outcomes. Co-design remains under-utilised or under-reported. Future research should prioritise co-designed, theory-informed interventions and improve reporting of health literacy subgroup analyses and participatory development processes.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148814416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Academic pharmacy must do better to accommodate its faculty workforce.","authors":"Shane P Desselle, Soutsada Sikhouchanh, Sukvinder Nijjar, Phillip Chao, Parisa Eskandari Heravi, Breteil Sourisho Chamaky","doi":"10.1016/j.sapharm.2026.08.004","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.08.004","url":null,"abstract":"<p><p>This commentary follows an insightful paper recently published on the current milieu in academic pharmacy. The paper was unique in that it reported the results of in-depth interviews of persons with previously well-established, successful careers as pharmacy faculty who left the academy for various alternative paths. The commentary reflects on that paper along with other current literatures and trends in academic pharmacy and the broader context of academia, particularly the evolving work environments for faculty. We argue that evolutions in the work of pharmacy academicians have been witness to losses in autonomy, heightened expectations for productivity, greater involvement in administrative bureaucracy, decrements in the teaching environment, and erosion in culture and collegiality vital for their success. Indeed, the results of the aforementioned and other studies present a complex picture of the current environment, yet we cannot let the complexity preclude more immediate actions to address culture, collegiality, autonomy, citizenship, and quality. We must move past lip service and take real actions to address these phenomena. Academic leadership should make examples of the actions of star, or top performing faculty, provide adequate mentorship and development for all faculty, and use clear and specific communication while avoiding general platitudes. They must encourage innovative solutions and reward those who proffer them. Faculty colleagues can take actions, themselves, to yield more collegial environments. Losing faculty talent is problematic not only for the institution, but for the entire academy, for students, the profession, the academic scientific disciplines comprising pharmacy, and for society at large.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148814373","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Francisco Javier Ferreira-Alfaya, Pilar Bas-Sarmiento, Martina Fernández-Gutiérrez, María José Zarzuelo-Romero
{"title":"Pharmaceutical pictograms: From fragmented evidence to accessible care.","authors":"Francisco Javier Ferreira-Alfaya, Pilar Bas-Sarmiento, Martina Fernández-Gutiérrez, María José Zarzuelo-Romero","doi":"10.1016/j.sapharm.2026.08.005","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.08.005","url":null,"abstract":"<p><p>Understanding medication-related messages is a core requirement of pharmaceutical care. Pharmaceutical pictograms, as visual aids complementing verbal and written communication, have long been proposed as a strategy to improve comprehension and promote the rational use of medicines. However, despite decades of research, their integration into routine pharmaceutical practice remains limited. This commentary argues that the limited application of pharmaceutical pictograms is primarily related to systemic fragmentation within the research landscape rather than to an absence of evidence. Diagnostic and implementation studies have largely evolved in parallel, without being articulated into coherent methodological pathways capable of generating cumulative evidence and supporting effective translation into practice. As a result, pictograms are frequently validated without progressing toward implementation, or implemented without prior cultural validation. Building on this critical analysis, we position pharmaceutical pictograms as a health literacy strategy and propose an integrative and replicable multistage protocol grounded in organizational health literacy and cultural competence principles. The model incorporates multidimensional diagnosis, iterative co-design and cultural validation, an essential educational intervention, and implementation with evaluation in real-world settings. By integrating educational, health care, and regulatory dimensions within a single methodological framework, the proposed model seeks to strengthen evidence accumulation and support the effective implementation of pharmaceutical pictograms in pharmaceutical care.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148833040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Jamaliah Jamari, Ernieda Hatah, Noraida Mohamed Shah
{"title":"Transitional care interventions and patient empowerment in adolescents and young adults with chronic conditions: A scoping review for medication management.","authors":"Jamaliah Jamari, Ernieda Hatah, Noraida Mohamed Shah","doi":"10.1016/j.sapharm.2026.08.003","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.08.003","url":null,"abstract":"<p><strong>Background: </strong>The transition from paediatric to adult healthcare for Adolescents and Young Adults (AYAs) with chronic conditions is critical, often marked by fragmented care, declining adherence, and worsening disease control. Although structured Transition of Care (TOC) frameworks exist, intervention components remain inconsistently defined, lack explicit theoretical grounding, and inadequately address competencies such as medication management.</p><p><strong>Objectives: </strong>This review aimed to (1) identify transitional care interventions for AYAs with chronic conditions; (2) classify intervention components using Psychological Empowerment Theory; (3) map components related to medication management; and (4) identify gaps in conceptualisation and implementation.</p><p><strong>Methods: </strong>A scoping review was conducted following JBI methodology and PRISMA-ScR guidelines. Scopus, Web of Science, and Ovid MEDLINE were searched for English-language studies published between January 2015 and January 2026. Eligible studies evaluated transitional care interventions incorporating medication management or empowerment components. Data were deductively mapped onto the intrapersonal, interactional, and behavioural domains of Psychological Empowerment Theory.</p><p><strong>Results: </strong>Thirty studies, representing a total of 3812 participants, were included. Interventions predominantly targeted interactional components, particularly disease knowledge, alongside behavioural components such as self-management. Intrapersonal constructs, including self-efficacy and psychosocial support, were least addressed and inconsistently operationalised. Pharmacist involvement was reported in only three studies (10%), primarily involving medication education and self-management skills training rather than longitudinal engagement across the transition pathway.</p><p><strong>Conclusion: </strong>By applying Psychological Empowerment Theory as an organising lens, this review shows that current TOC interventions prioritise knowledge and skills while underemphasising intrapersonal empowerment, risking the conflation of knowledge with empowerment and highlighting gaps in supporting sustained medication management. Future research should develop theoretically grounded, multidisciplinary models integrating clinical pharmacy expertise across the transition pathway.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148799715","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Kristin Xenos, Charlotte E Rees, Ian M Heslop, Shalom I Benrimoj, Sarah Dineen-Griffin
{"title":"Evaluating pharmacist prescribing education programs: A realist synthesis.","authors":"Kristin Xenos, Charlotte E Rees, Ian M Heslop, Shalom I Benrimoj, Sarah Dineen-Griffin","doi":"10.1016/j.sapharm.2026.07.003","DOIUrl":"https://doi.org/10.1016/j.sapharm.2026.07.003","url":null,"abstract":"<p><strong>Background/introduction: </strong>Pharmacist prescribing has evolved to meet healthcare system needs, but the effectiveness, mechanisms, and contextual factors influencing pharmacist prescribing education programs across undergraduate, postgraduate, and continuing professional development (CPD) contexts remains poorly understood.</p><p><strong>Objectives/aim: </strong>This realist synthesis explores how pharmacy prescribing education programs work (or not), for whom, under what circumstances, and why.</p><p><strong>Methods: </strong>After developing an initial program theory from grey literature, a realist synthesis using Pawson's key stages were followed: (i) clarifying the scope; (ii) determining the search strategy; (iii) study selection and appraisal of documents; (iv) data extraction; and (v) analysis and synthesis processes. The RAMESES I (Realist And Meta-narrative Evidence Syntheses - Evolving Standards) publication standards were followed. Context-mechanism-outcome configurations (CMOCs) of varied pharmacy prescribing education programs were extracted and recurring patterns were synthesised to refine the initial program theory.</p><p><strong>Results: </strong>Twenty-three articles were included. One recurring CMOC pattern was identified for undergraduate prescribing programs, nine for postgraduate programs, and four for CPD programs. While all three educational settings could generate positive outcomes, cross-category analysis revealed several shared patterns: Experiential learning could generate confidence in both undergraduate and postgraduate programs; social learning could generate satisfaction in postgraduate and CPD programs; and positive student-educator relationships could generate satisfaction in postgraduate and CPD programs.</p><p><strong>Conclusion: </strong>Pharmacist prescribing education programs seem to be most effective when designed to trigger mechanisms producing desired outcomes (knowledge, skills, confidence, and satisfaction) within their specific contexts. Experiential and social learning emerged as key drivers of successful programs. These findings offer practical guidance for educators and policymakers to optimise prescribing education and inform future realist evaluations exploring contextual influences with greater clarity.</p><p><strong>Registration: </strong>PROSPERO: CRD420251056576; Protocol reference: Xenos K, Rees CE, Heslop IM, Benrimoj SI, Dineen-Griffin S. Evaluating pharmacist prescribing education programmes: a realist synthesis protocol. BMJ Open. 2025; 15(8):e105951.</p>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":" ","pages":""},"PeriodicalIF":3.4,"publicationDate":"2026-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148898177","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Simone Tan , Lynne Emmerton , Billy Sung , Bandana Saini , Tin Fei Sim
{"title":"Doing things differently: Integrating evidence-based marketing frameworks into pharmacy practice to promote respiratory health services","authors":"Simone Tan , Lynne Emmerton , Billy Sung , Bandana Saini , Tin Fei Sim","doi":"10.1016/j.sapharm.2025.12.003","DOIUrl":"10.1016/j.sapharm.2025.12.003","url":null,"abstract":"<div><div>Accessible health services play a crucial role in the management of chronic conditions such as asthma and chronic obstructive pulmonary disease, and the associated reduction in their corresponding morbidity and mortality rates. The evolution of the community pharmacist's role, combined with the highly accessible community pharmacy setting, positions pharmacists as key providers of timely, preventive, and supportive interventions for respiratory health.</div><div>Despite the use of theories such as the Capability, Opportunity, Motivation, and Behavior (COM-B) model or Theoretical Domains Framework to guide the implementation of professional services, the uptake of respiratory health services in community pharmacies remains inconsistent across pharmacies and service types, presenting a lost opportunity to improve outcomes for people living with chronic respiratory conditions. Whilst these frameworks recognize communication and marketing as key factors influencing successful service implementation, they were not developed to guide the systematic marketing, communication, or promotion of these services to patients and the wider community.</div><div>The commercial sector has long leveraged evidence-based marketing frameworks, segmentation and targeting approaches, and promotional strategies to systematically guide the planning, execution, and evaluation of its marketing activities. These frameworks or models are designed to provide clarity and consistency, ensuring that marketing decisions are not <em>ad hoc</em> or reactive, but are instead aligned with the broader goals of the organizations involved. Given the success of these approaches, we assert that adapting such frameworks within pharmacy health services can enhance understanding of consumer psychology and, in turn, enable us to market these services more effectively.</div><div>This commentary advocates the need for exploring how pharmacy services can be better communicated and marketed to potential health consumers, using respiratory health services as an example.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 3","pages":"Pages 501-503"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145709928","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Rachel L. Hill , Nathan M. D'Cunha , Sam Kosari , Claire Pearce , Mark Naunton , Helen Holloway , Kasia Bail , Diane Gibson , Stephen Isbel
{"title":"Outcomes of pharmacist interventions as part of EAHOP – Enhancing allied health for older people in residential care","authors":"Rachel L. Hill , Nathan M. D'Cunha , Sam Kosari , Claire Pearce , Mark Naunton , Helen Holloway , Kasia Bail , Diane Gibson , Stephen Isbel","doi":"10.1016/j.sapharm.2025.11.008","DOIUrl":"10.1016/j.sapharm.2025.11.008","url":null,"abstract":"<div><div>The EAHOP trial (Enhancing Allied Health for Older People in Residential Care) Outcomes of pharmacist interventions.</div></div><div><h3>Background</h3><div>The pharmacist has a critical role in the multidisciplinary team (MDT) when contributing to the care of older people living in residential aged care. The EAHOP study is a clinical trial that embedded a pharmacist within an MDT in a residential aged care home. This abstract reports on the pharmacy results of the study.</div></div><div><h3>Method</h3><div>This study used a mixed method to describe key pharmacy outcome measures of direct and indirect time per resident, number of recommendations accepted and to describe the thoughts, opinions and experience of key stakeholders.</div></div><div><h3>Results</h3><div>There were 124 recommendations made by the pharmacist for 34 residents, an average of 3.65 per resident, higher than the usual 2.7 recommendations per RMMR. At the GP case conferences 70 % were accepted, 9 % were declined and 21 % were not discussed. An average of 61 min direct time and 246 min of indirect time was spent per resident. Qualitative findings showed the pharmacy role improved care for residents by enhancing communication between health professionals, staff, residents and families.</div></div><div><h3>Conclusion</h3><div>The EAHOP model can supplement existing models of pharmacy intervention in residential care by providing organised multidisciplinary collaboration between the General Practitioner, nursing, pharmacist and allied health disciplines.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 3","pages":"Pages 435-442"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145655631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Sofa D. Alfian , Qisty A. Khoiry , Hasna S.M. Isman , Aulia Iskandarsyah , Ivan S. Pradipta , Rizky Abdulah
{"title":"Exploring the readiness of healthcare providers for scaling up telehealth services beyond the COVID-19 pandemic: A mixed method study","authors":"Sofa D. Alfian , Qisty A. Khoiry , Hasna S.M. Isman , Aulia Iskandarsyah , Ivan S. Pradipta , Rizky Abdulah","doi":"10.1016/j.sapharm.2025.12.008","DOIUrl":"10.1016/j.sapharm.2025.12.008","url":null,"abstract":"<div><h3>Background</h3><div>The coronavirus disease 2019 (COVID-19) pandemic accelerated digital health transformation, forcing healthcare providers to immediately implement telehealth services without adequate assessment of their readiness.</div></div><div><h3>Objective</h3><div>This study aims to explore the readiness of healthcare providers to scale up telehealth services in Indonesia.</div></div><div><h3>Methods</h3><div>A sequential mixed method was used with an explanatory study design. A cross-sectional survey using the translated and validated Telehealth Readiness Assessment (TRA) tool was conducted among general practitioners and pharmacists from public clinics in Bandung City, Indonesia. This was followed by a qualitative study using in-depth interviews and focus group discussions (FGDs) to explore the underlying reasons among those who showed low readiness observed from quantitative results. Quantitative and qualitative data analyses were performed for each type of healthcare provider.</div></div><div><h3>Results</h3><div>The results showed that in total, 63 general practitioners and 86 pharmacists, completed the survey, a majority of whom were female including 64 % of general practitioners and 72 % of pharmacists. Most of general practitioners showed moderate readiness, while most of pharmacists demonstrated high readiness to implement telehealth services. There were no significant correlations between readiness to implement telehealth services with age, sex, education level, and duration of experience (p > 0.05). A total of six females aged between 26 and 50 years participated in the in-depth interviews and FGDs. Among those who showed low readiness, organizational leadership, financial considerations, operational difficulties, staff engagement, and patient participation were mentioned as the main reasons. Differences in these underlying reasons were observed between general practitioners and pharmacists.</div></div><div><h3>Conclusion</h3><div>Differences are observed in the levels at which general practitioners and pharmacists are ready to scale up telehealth services. The underlying reasons for the low readiness are specific to the type of healthcare providers and affected by organizational, operational, and technological factors, but independent of sociodemographic factors.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 3","pages":"Pages 482-490"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145865991","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ensuring the quality use of medicines in clinical trials: A review and perspective on optimising the role of pharmacists","authors":"Beata Bajorek","doi":"10.1016/j.sapharm.2025.11.004","DOIUrl":"10.1016/j.sapharm.2025.11.004","url":null,"abstract":"<div><h3>Objectives</h3><div>Given that a most clinical trials investigate potential or established medicines, it should be obvious that pharmacists, as ‘<em>medicines experts</em>’, would play a key role in such. The aim of this article was to narrate a perspective on the role of the pharmacist in clinical trials, drawing out the way that pharmacists are currently represented within clinical trials guidance documents.</div></div><div><h3>Methods</h3><div>This narrated review and perspective explored relevant international literature relating to clinical trial governance, particularly from the Australian setting where such documents have been recently developed and/or revised, providing a contemporary representation.</div></div><div><h3>Results</h3><div>Clinical trial guidance documents describing the role of pharmacists show that quality use of medicines principles are not well applied to the trial context. As such, pharmacists are underutilised in their role as medicines experts and as clinicians supporting optimal medicines use along the medication management pathway. Presently, guidance documents portray pharmacists as having largely administrative roles, focused on compliance with trial protocols, policies and legislation. Any clinical role appears relatively limited to drug handling. There is a need for capacity building in clinical trial to better recognise and utilise pharmacists’ expertise, including them in the design, conduct, and leadership of clinical trials.</div></div><div><h3>Conclusions</h3><div>There is both scope and need to more directly include pharmacists in clinical trials. Wherever medicines are used, a pharmacist should be present and/or substantively involved in assuring the quality use of medicines, including within the full range of clinical trials. To support pharmacists, part of the global investment into clinical research should include an investment into clinical pharmacy services to ensure the quality use of medicines throughout the trial process alongside effective translation into clinical practice.</div></div>","PeriodicalId":48126,"journal":{"name":"Research in Social & Administrative Pharmacy","volume":"22 3","pages":"Pages 363-369"},"PeriodicalIF":2.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145641296","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}